The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment
Abstract Background Assessment of Ki67 by immunohistochemistry (IHC) has limited utility in clinical practice owing to analytical validity issues. According to International Ki67 Working Group (IKWG) guidelines, treatment should be guided by a prognostic test in patients expressing intermediate Ki67...
| Autores principales: | , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
Wiley
2023-06-01
|
| Colección: | Cancer Medicine |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1002/cam4.6032 |